Evaluation of the anti‑proliferative activity of violacein, a natural pigment of bacterial origin, in urinary bladder cancer cell lines

Neroni,Bruna; Zingaropoli,Maria Antonella; Radocchia,Giulia; Ciardi,Maria Rosa; Mosca,Luciana; Pantanella,Fabrizio; Schippa,Serena

doi:10.3892/ol.2022.13252

Evaluation of the anti‑proliferative activity of violacein, a natural pigment of bacterial origin, in urinary bladder cancer cell lines

Authors:
- Bruna Neroni
- Maria Antonella Zingaropoli
- Giulia Radocchia
- Maria Rosa Ciardi
- Luciana Mosca
- Fabrizio Pantanella
- Serena Schippa
View Affiliations

Affiliations: Department of Public Health and Infectious Diseases, Microbiology Section, Sapienza University of Rome, I-00185 Rome, Italy, Department of Biochemical Sciences, Sapienza University of Rome, I-00185 Rome, Italy
Published online on: February 23, 2022 https://doi.org/10.3892/ol.2022.13252
Article Number: 132

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Violacein is a natural pigment, a pyrrolidone, and a bisindole derived from the condensation of two tryptophan molecules, which gives a blue violet color to several gram‑negative violacein‑producing bacteria. Violacein production provides a competitive advantage against antagonistic species or predators. In addition, the compound has antibacterial, antifungal, antiviral, and antioxidant activities. Several studies on colon, breast, and head and neck cancer lines have already demonstrated the anti‑proliferative potential of violacein. Bladder cancer is one of the most common types of cancer in urology. The therapeutic approach is mainly based on surgery, chemotherapy, and immunotherapy. The aim of the present study was to evaluate the anti‑proliferative activity of violacein against the human bladder cancer cell lines, HTB4 (T24) and HTB9 (5637), using low‑grade and high‑grade transitional cell carcinoma models, respectively, which has never been assayed before. For this purpose, the potential violacein anti‑proliferative effect on T24 and 5637 cells was evaluated by studying the cell viability, proliferation, cell cycle, and caspase‑3 activation. The results showed that violacein had anti‑proliferative activity in the two cell lines, which was greater for the second‑stage bladder cancer cell line (5637), and a different mode of action against the two cell lines.

View Figures

View References

1	Ramesh C, Vinithkumar NV, Kirubagaran R, Venil CK and Dufossé L: Multifaceted applications of microbial pigments: Current knowledge, challenges and future directions for public health implications. Microorganisms. 7:1862019. View Article : Google Scholar : PubMed/NCBI
2	Choi SY, Lim S, Cho G, Kwon J, Mun W, Im H and Mitchell RJ: Chromobacterium violaceum delivers violacein, a hydrophobic antibiotic, to other microbes in membrane vesicles. Environ Microbiol. 22:705–713. 2020. View Article : Google Scholar : PubMed/NCBI
3	Durán N, Justo GZ, Durán M, Brocchi M, Cordi L, Tasic L, Castro GR and Nakazato G: Advances in Chromobacterium violaceum and properties of violacein-Its main secondary metabolite: A review. Biotechnol Adv. 34:1030–1045. 2016. View Article : Google Scholar : PubMed/NCBI
4	Choi SY, Yoon K, Lee JI and Mitchell RJ: Violacein: Properties and production of a versatile bacterial pigment. Biomed Res Int. 2015:4650562015. View Article : Google Scholar : PubMed/NCBI
5	Pantanella F, Berlutti F, Passariello C, Sarli S, Morea C and Schippa S: Violacein and biofilm production in Janthinobacterium lividum. J Appl Microbiol. 102:992–999. 2007.PubMed/NCBI
6	Cazoto LL, Martins D, Ribeiro MG, Durán N and Nakazato G: Antibacterial activity of violacein against Staphylococcus aureus isolated from bovine mastitis. J Antibiot (Tokyo). 64:395–397. 2011. View Article : Google Scholar : PubMed/NCBI
7	Sasidharan A, Sasidharan NK, Amma DB, Vasu RK, Nataraja AV and Bhaskaran K: Antifungal activity of violacein purified from a novel strain of Chromobacterium sp. NIIST (MTCC 5522). J Microbiol. 53:694–701. 2015. View Article : Google Scholar : PubMed/NCBI
8	Bilsland E, Tavella TA, Krogh R, Stokes JE, Roberts A, Ajioka J, Spring DR, Andricopulo AD, Costa FT and Oliver SG: Antiplasmodial and trypanocidal activity of violacein and deoxyviolacein produced from synthetic operons. BMC Biotechnol. 18:222018. View Article : Google Scholar : PubMed/NCBI
9	Rodrigues AL, Trachtmann N, Becker J, Lohanatha AF, Blotenberg J, Bolten CJ, Korneli C, de Souza Lima AO, Porto LM, Sprenger GA and Wittmann C: Systems metabolic engineering of Escherichia coli for production of the antitumor drugs violacein and deoxyviolacein. Metab Eng. 20:29–41. 2013. View Article : Google Scholar : PubMed/NCBI
10	Hashimi SM, Xu T and Wei MQ: Violacein anticancer activity is enhanced under hypoxia. Oncol Rep. 33:1731–1736. 2015. View Article : Google Scholar : PubMed/NCBI
11	Ferreira CV, Bos CL, Versteeg HH, Justo GZ, Durán N and Peppelenbosch MP: Molecular mechanism of violacein-mediated human leukemia cell death. Blood. 104:1459–1464. 2004. View Article : Google Scholar : PubMed/NCBI
12	Elmore S: Apoptosis: A review of programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
13	Zeiss CJ: The apoptosis-necrosis continuum: Insights from genetically altered mice. Vet Pathol. 40:481–495. 2003. View Article : Google Scholar : PubMed/NCBI
14	Kerr JF, Winterford CM and Harmon BV: Apoptosis. Its significance in cancer and cancer therapy. Cancer. 73:2013–2026. 1994. View Article : Google Scholar : PubMed/NCBI
15	de Carvalho DD, Costa FTM, Duran N and Haun M: Cytotoxic activity of violacein in human colon cancer cells. Toxicol In Vitro. 20:1514–1521. 2006. View Article : Google Scholar : PubMed/NCBI
16	Alshatwi AA, Subash-Babu P and Antonisamy P: Violacein induces apoptosis in human breast cancer cells through up regulation of BAX, p53 and down regulation of MDM2. Exp Toxicol Pathol. 68:89–97. 2016. View Article : Google Scholar : PubMed/NCBI
17	Masuelli L, Pantanella F, La Regina G, Benvenuto M, Fantini M, Mattera R, Stefano ED, Mattei M, Silvestri R, Schippa S, et al: Violacein, an indole-derived purple-colored natural pigment produced by Janthinobacterium lividum, inhibits the growth of head and neck carcinoma cell lines both in vitro and in vivo. Tumour Biol. 37:3705–3717. 2016. View Article : Google Scholar : PubMed/NCBI
18	Kodach LL, Bos CL, Durán N, Peppelenbosch MP, Ferreira CV and Hardwick JCH: Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells. Carcinogenesis. 27:508–516. 2006. View Article : Google Scholar : PubMed/NCBI
19	de Sousa Leal AM, de Queiroz JDF, de Medeiros SRB, de Souza Lima TK and Agnez-Lima LF: Violacein induces cell death by triggering mitochondrial membrane hyperpolarization in vitro. BMC Microbiol. 15:1152015. View Article : Google Scholar : PubMed/NCBI
20	American Cancer Society: Key Statistics for Bladder Cancer. https://www.cancer.org/cancer/bladder-cancer/about/key-statistics.htmlNovember 10–2021PubMed/NCBI
21	Professionals S-O: EAU Guidelines: Non-muscle-invasive Bladder Cancer. Uroweb. https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/November 10–2021
22	Burger M, Catto JWF, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, Vecchia CL, Shariat S and Lotan Y: Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 63:234–241. 2013. View Article : Google Scholar : PubMed/NCBI
23	DeGeorge KC, Holt HR and Hodges SC: Bladder cancer: Diagnosis and treatment. Am Fam Physician. 96:507–514. 2017.PubMed/NCBI
24	Kumar P, Nagarajan A and Uchil PD: Analysis of cell viability by the MTT assay. Cold Spring Harb Protoc. Jun 1–2018.doi: 10.1101/pdb.prot095505, 2018. View Article : Google Scholar
25	Davis JD: The evolution of the progressive-era hemocytometer. Caduceus. 11:164–183. 1995.PubMed/NCBI
26	Porter AG and Jänicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999. View Article : Google Scholar : PubMed/NCBI
27	Bromberg N, Dreyfuss JL, Regatieri CV, Palladino MV, Durán N, Nader HB, Haun M and Justo GZ: Growth inhibition and pro-apoptotic activity of violacein in Ehrlich ascites tumor. Chem Biol Interact. 186:43–52. 2010. View Article : Google Scholar : PubMed/NCBI
28	Cohen GM: Caspases: The executioners of apoptosis. Biochem J. 326:1–16. 1997. View Article : Google Scholar : PubMed/NCBI